FDA Approves Vosoritide for Children With Achondroplasia : c

Vosoritide is a daily injection for children with achondroplasia who have open epiphyses, given under the skin and administered by a caregiver.

Related Keywords

Australia , Japan , Brazil , William Wilcox , European Society For Paediatric Endocrinology Meeting , Emory University , Biomarin Pharmaceutical Inc , Paediatric Endocrinology Meeting , European Medicines Agency , Medicinal Products , Human Use ,